Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nephrotic Syndrome, Minimal Change”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04369183
What this trial is testing

Rituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change Disease
Istanbul University 25
Not applicableNot Yet RecruitingNCT07685093
What this trial is testing

Comparison of Efficacy and Safety of Albumin Versus Fresh Frozen Plasma in Managing Diuretic Resistant Edema in Children With Idiopathic Nephrotic Syndrome.

Who this might be right for
Idiopathic Nephrotic Syndrome (INS)
Qamar Shafiq 56
Testing effectiveness (Phase 2)Ended earlyNCT02394106
What this trial is testing

Ofatumumab in Children With Drug Resistant Idiopathic Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Istituto Giannina Gaslini 13
Large-scale testing (Phase 3)UnknownNCT02896270
What this trial is testing

Valproic Acid for Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic SyndromeFocal Segmental GlomerulosclerosisMinimal Change Disease
Universitair Ziekenhuis Brussel 15
Not applicableLooking for participantsNCT04207580
What this trial is testing

A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.

Who this might be right for
Idiopathic Nephrotic Syndrome
University Hospital, Limoges 1,180
Not applicableStudy completedNCT01113385
What this trial is testing

Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome

Who this might be right for
Focal Segmental GlomerulosclerosisSteroid Resistant Nephrotic Syndrome
Children's National Research Institute 7
Not applicableStudy completedNCT07702981
What this trial is testing

Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

Who this might be right for
Membranous NephropathyMinimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS)
University Hospital, Ioannina 40
Not applicableEnded earlyNCT04235621
What this trial is testing

Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Who this might be right for
Glomerulosclerosis, Focal SegmentalMinimal Change DiseaseDiabetic Nephropathies
Goldfinch Bio, Inc. 20
Not applicableNot Yet RecruitingNCT06315504
What this trial is testing

Circulating Factors in Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeMembranous NephropathyMinimal Change Disease+1 more
Iain Bressendorff 104
Large-scale testing (Phase 3)Study completedNCT01092962
What this trial is testing

Cyclophosphamide Versus Mycophenolate Mofetil for the Treatment of Steroid-dependent Nephrotic Syndrome in Children

Who this might be right for
Idiopathic Nephrotic Syndrome
Assistance Publique - Hôpitaux de Paris 70
Post-approval studies (Phase 4)Not Yet RecruitingNCT07151456
What this trial is testing

Short-term gluCOCOrticoid in Adult STEROID-sensitive Nephrotic Syndrome: The COCO-ASTEROID Study

Who this might be right for
Idiopathic Nephrotic Syndrome
First Affiliated Hospital of Wenzhou Medical University 224
Large-scale testing (Phase 3)Active Not RecruitingNCT05627557
What this trial is testing

Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome

Who this might be right for
Childhood Idiopathic Nephrotic Syndrome
Hoffmann-La Roche 85
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Not applicableLooking for participantsNCT05588063
What this trial is testing

TaVNS for FRNS in Children

Who this might be right for
Nephrotic Syndrome in ChildrenMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Northwell Health 30
Large-scale testing (Phase 3)Study completedNCT00065611
What this trial is testing

Steroid Treatment for Kidney Disease

Who this might be right for
NephrosisFocal Lipoid Glomerulosclerosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 8
Not applicableLooking for participantsNCT06820866
What this trial is testing

Non-invasive Diagnosis of Idiopathic Nephrotic Syndromes

Who this might be right for
Idiopathic Nephrotic Syndrome (INS)
Assistance Publique - Hôpitaux de Paris 265
Testing effectiveness (Phase 2)Study completedNCT02394119
What this trial is testing

Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor Dependent Idiopathic Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Istituto Giannina Gaslini 140
Post-approval studies (Phase 4)Study completedNCT01185197
What this trial is testing

Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study

Who this might be right for
Nephrosis, Lipoid
The University of Hong Kong 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06635720
What this trial is testing

REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)

Who this might be right for
Nephrotic Syndrome in ChildrenNephrotic Syndrome, Minimal ChangeNephrotic Syndrome+1 more
The Hospital for Sick Children 50
Large-scale testing (Phase 3)UnknownNCT03501459
What this trial is testing

Lymphocyte Markers As Predictors Of Responsiveness To Rituximab Among Patients With Idiopathic Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
National University Health System, Singapore 100
Next Page